iMediSync Inc. of Seoul at MEDICA 2021 in Düsseldorf -- MEDICA - World Forum for Medicine
Manage stand orders
Select Option

iMediSync Inc.

5th, Floor, 175 Yeoksam-Ro, Gangnam-Gu, Seoul, 06247 Seoul
Korea, Republic
Telephone +82 2 7477422, +82 10 57118441

Submit your contact details

Provide your contact details to the exhibitor. Optionally, you may also add a personal message.

Please log in

You must be logged in to send the contact request.

An error has occurred

Please check your internet connection or try again later.

Message has been sent

Your message to the exhibitor was sent successfully.

Hall map

MEDICA 2021 hall map (Hall 16): stand F56

Fairground map

MEDICA 2021 fairground map: Hall 16


Dr DaeKeun Kim

iSyncWave Project Leader
Director of Corporate Research Center



Kim JaeWoo

International Sales Director



Please log in

You must be logged in to use matchmaking

Please log in for matchmaking

Registration is required to use the networking service and a separate registration for matchmaking. Please register for Matchmaking first.

Let's get started!

Welcome to Matchmaking. Would you like to get in touch with ?

Our range of products

Product categories

  • 01  Imaging and diagnostics / medical equipment and devices
  • 01.01  Diagnostics
  • 01.01.06  Neurological diagnosis, apparatus and instruments

Neurological diagnosis, apparatus and instruments

Our products

Product category: Neurological diagnosis, apparatus and instruments


iMediSync Inc developed an innovative 19 channel dry EEG headset called iSyncWave combining with AI based automatic EEG/HRV analysis platform called iSyncBrain/iSyncHeart. The iSyncWave has an expandible structure using special gears and springs while maintaining 10/20 international electrode system. Combining special mechanical structures and soft electrodes coated with Ag/AgCl gives a quality EEG signal within a few minutes. The special analog front end design is applied for maximizing signal to noise ratio in various environment. PPG signal is also measured with 19 channel EEG at the same time. Furthermore, iSyncWave gives an automated EEG/HRV analysis platform which gives a AI denoising, age and sex matched norm comparison, early detection of mild cognitive impairment, and HRV analysis. (iSyncWave is ready for the KFDA, FDA and CE are not cleared yet. iSyncBrain/iSyncHeart is registered as a KFDA software medica device)

More Less

Company news



13 Nov 2021

iSyncBrain QEEG amyloidopathy model published online in Frontiers computational neuroscience

Paper titled below
Machine Learning to Predict Brain Amyloid Pathology in Pre-dementia Alzheimer’s Disease Using QEEG Features and Genetic Algorithm Heuristic. 

iMediSync will add this model with current MCI model in iSyncBrain AI QEEG automated mental health analysis platform  after validation clinical study. iSyncWave dry headset can be widely utilized for early detection of the Alzheimer disease soon.     

More Less

30 Oct 2021

iSyncwave finally get the CB safety cert, EMC cert and Biocompatibility cert.

After getting Korean, US and EU EMC cert, iMediSync finally get the iSyncWave CB safety and essential performace cert as an dry EEG acquisition device for US, EU, Japan and Korea, On Oct 28th. iSyncWave also get the Biocomaptibility cert on Oct 30th. Now ready for final technical documentation steps. After full clearance, iSyncWave can be used as an easy EEG acquisition device for various clinical settings, such as ealry screening of mild cognitive impairment, phamaceutical efficacy predictions, telemental care services especially in pandemic seasons as well as routine clinical practices.  Taking advantage of  iSyncWave simple dry EEG acqusition process and iSyncBrain AI automated analysis cloud pipelines, future mental health service can be accelated in various circumstances, especailly in school settings for child and adolescent, in annual mental checkup settings , in phamaceutical development settings using EEG phenotypings and in public and private insurance developement settings with iSyncBrain precision biomarkers such as MCI detections, Alzheimer disease detecions.  

More Less

About us

Company portrait

iMediSync Inc has developed a digital mental care platform providing EEG biomarkers and digital therapeutics for early detection and treatment of dementia  other neuropsychiatric disorders, which comprised of iSyncWave 19 channel dry EEG/PPG device, iSyncBrain/Heart  AI geared automated QEEG/HRV analysis with healthy normative database and machine learning biomarker,  and photobiomodulation headset with telemental care web dashboard.  iMediSync originated from National Standard Data Center for Korean EEG, Seoul National University which has developed world first sex classified QEEG normative DB with more than 1300 healthy subjects ranging from 4 – 82 years old. The QEEG guided machine learning biomarker for early detection of Alzheimer dementia, iSyncBrain Digital EEG solution and  iSyncHeart  HRV analysis soution are registerd as software meidcal device in Korean FDA. Combining iSyncBrain/iSyncHeart  with recently developed iSyncWave, quality EEG and HRV can be conviently measured by simply wearing a headset and connected automated QEEG/HRV analysis including norm comparison and MCI(mild cognitive impairment) probabilities can be integrated with routine clinical practices, insurance designs, annual mental checkup, clinical studies for phamacetutical development, and telemental care serives.